Cuprina Holdings (Cayman) Ltd (CUPR) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · Nasdaq
Cuprina Holdings (Cayman) Ltd (CUPR) stock forecast summary
On Oct. 16, 2026, CUPR is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5172 stocks scored that day.
Cuprina Holdings (Cayman) Ltd is a small-cap company with a market capitalization of $13M. It ranks number 20 by market capitalization among the 27 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast.
For CUPR, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 58.0%, measured on 211 forecast dates between 2025-05-16 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 32.0%, measured on 254 forecast dates between 2025-05-16 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.0%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CUPR included.
Follow CUPR freeCUPR price chart and AI forecast
How CUPR ranks among 5172 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Cuprina Holdings (Cayman) Ltd (CUPR) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric. Statement values were filed in SGD and are shown converted to USD (flows at the trailing twelve-month average rate, balances at the balance-sheet date rate).
Financial statement data is not available for this company: its filings are not in a form the pipeline converts, so only market data is shown.
Valuation & Market
| Metric | CUPR | Rank |
|---|---|---|
| Market Cap | $13M | 20/27 |
Dividend & Shareholder Information
| Metric | CUPR | Rank |
|---|---|---|
| Shares Outstanding | 7M | – |
CUPR quarterly financials and insider trading
Cuprina Holdings (Cayman) Ltd (CUPR) industry peers
Companies classified under the same SEC industry code as Cuprina Holdings (Cayman) Ltd (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 27 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| CUPR Cuprina Holdings (Cayman) Ltd | ▶ | $13M |
| ISRG Intuitive Surgical Inc | ▼ | $150.74B |
| STE Steris Plc | ▼ | $21.71B |
| ZBH Zimmer Biomet Holdings, Inc. | ▼ | $18.12B |
| SNN Smith & Nephew Plc | ▼ | $12.75B |
| ALGN Align Technology Inc | ▶ | $10.46B |
| MSA Msa Safety Inc | ▼ | $6.91B |
| ESTA Establishment Labs Holdings Inc. | ▲ | $1.76B |
| ENOV Enovis Corp | ▶ | $1.13B |
| CDRE Cadre Holdings, Inc. | ▶ | $1.13B |
| AVR Anteris Technologies Global Corp. | ▶ | $590M |
| SMTI Sanara Medtech Inc. | ▼ | $305M |
| INGN Inogen Inc | ▶ | $166M |
| LAKE Lakeland Industries Inc | ▲ | $90M |
| NTRB Nutriband Inc. | ▲ | $76M |
| APT Alpha Pro Tech Ltd | ▶ | $57M |
| COCH Envoy Medical, Inc. | ▶ | $52M |
| MYO Myomo, Inc. | ▲ | $48M |
| MLSS Milestone Scientific Inc. | ▲ | $29M |
| LFWD Lifeward Ltd. | ▲ | $17M |
| UEEC United Health Products, Inc. | ▲ | $12M |
| RGNT Regentis Biomaterials Ltd. | ▲ | $11M |
| CLGN Collplant Biotechnologies Ltd | ▶ | $7M |
| LGMK Logicmark, Inc. | ▲ | $1M |
| BBLG Bone Biologics Corp | ▲ | $1M |
| RBOT Vicarious Surgical Inc. | ▲ | $550K |
| FEED Envue Medical, Inc. | ▼ | $340K |
Where CUPR sits on the market map
Cuprina Holdings (Cayman) Ltd (CUPR) stock news
Loading...
Cuprina Holdings (Cayman) Ltd (CUPR) stock forecast FAQ
What is the Cuprina Holdings (Cayman) Ltd (CUPR) stock forecast?
On Oct. 16, 2026, CUPR is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5172 stocks scored that day.
How accurate are Cuprina Holdings (Cayman) Ltd stock predictions?
For CUPR, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 58.0%, measured on 211 forecast dates between 2025-05-16 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 32.0%, measured on 254 forecast dates between 2025-05-16 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Cuprina Holdings (Cayman) Ltd forecasts updated?
Cuprina Holdings (Cayman) Ltd forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Cuprina Holdings (Cayman) Ltd's industry peers?
27 issuers in our coverage, CUPR included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Smith & Nephew Plc (SNN), Align Technology Inc (ALGN), Msa Safety Inc (MSA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.